KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Dynavax Technologies (DVAX) Payables (2016 - 2025)

Historic Payables for Dynavax Technologies (DVAX) over the last 16 years, with Q3 2025 value amounting to $44.0 million.

  • Dynavax Technologies' Payables rose 52097.62% to $44.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $44.0 million, marking a year-over-year increase of 52097.62%. This contributed to the annual value of $9.1 million for FY2024, which is 7275.5% up from last year.
  • Dynavax Technologies' Payables amounted to $44.0 million in Q3 2025, which was up 52097.62% from $42.7 million recorded in Q2 2025.
  • Dynavax Technologies' Payables' 5-year high stood at $44.0 million during Q3 2025, with a 5-year trough of $2.4 million in Q1 2024.
  • Moreover, its 5-year median value for Payables was $4.6 million (2024), whereas its average is $9.8 million.
  • Its Payables has fluctuated over the past 5 years, first crashed by 6668.04% in 2024, then surged by 83791.44% in 2025.
  • Quarter analysis of 5 years shows Dynavax Technologies' Payables stood at $2.6 million in 2021, then grew by 23.5% to $3.2 million in 2022, then surged by 63.34% to $5.2 million in 2023, then skyrocketed by 72.76% to $9.1 million in 2024, then soared by 385.83% to $44.0 million in 2025.
  • Its last three reported values are $44.0 million in Q3 2025, $42.7 million for Q2 2025, and $4.3 million during Q1 2025.